MWNA
AEMD icon

Marshall Wace North America’s Aethlon Medical AEMD Stock Holding History

Marshall Wace North America’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5
Closed -$98K – 1397
2021
Q2 		$98K Buy
+5
New +$57.6K ﹤0.01% 1385

Other funds holding AEMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CFN
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

Marshall Wace North America's AEMD Position: Q3 2021 in Review

Marshall Wace North America sold out of Aethlon Medical (AEMD) in Q3 2021, closing a stake of 5 shares — an estimated $98K sold.

Marshall Wace North America first reported a position in AEMD in Q2 2021 and held it in 1 quarter. The position peaked at $98K in Q2 2021. 14 funds tracked by Wall St. Rank hold AEMD as of Q3 2021.

  • Marshall Wace North America reported no remaining Aethlon Medical position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 5 Aethlon Medical shares in Q3 2021, an estimated $98K.
  • Marshall Wace North America first reported a position in Aethlon Medical in Q2 2021 and held it in 1 quarter.
  • Marshall Wace North America's Aethlon Medical position peaked at $98K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Aethlon Medical as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.